Spire Wealth Management’s Zimmer Biomet ZBH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.15K Buy
25
+9
+56% +$789 ﹤0.01% 1996
2026
Q1
$1.45K Sell
16
-137
-90% -$12.6K ﹤0.01% 2090
2025
Q4
$13.8K Sell
153
-30
-16% -$2.85K ﹤0.01% 1615
2025
Q3
$18K Buy
183
+95
+108% +$9.41K ﹤0.01% 1561
2025
Q2
$8.03K Sell
88
-17,068
-99% -$1.65M ﹤0.01% 1796
2025
Q1
$1.94M Buy
17,156
+15,861
+1,225% +$1.7M 0.06% 272
2024
Q4
$137K Buy
1,295
+946
+271% +$102K ﹤0.01% 934
2024
Q3
$37.7K Buy
349
+74
+27% +$8.08K ﹤0.01% 1223
2024
Q2
$29.8K Sell
275
-722
-72% -$85.1K ﹤0.01% 1289
2024
Q1
$132K Sell
997
-112
-10% -$14K ﹤0.01% 915
2023
Q4
$137K Sell
1,109
-109
-9% -$12.2K ﹤0.01% 900
2023
Q3
$137K Sell
1,218
-105
-8% -$13.3K 0.01% 833
2023
Q2
$193K Buy
1,323
+194
+17% +$26.4K 0.01% 727
2023
Q1
$146K Buy
1,129
+885
+363% +$111K 0.01% 832
2022
Q4
$31K Sell
244
-1
-0.4% -$116 ﹤0.01% 1188
2022
Q3
$26K Sell
245
-910
-79% -$99.9K ﹤0.01% 1231
2022
Q2
$121K Sell
1,155
-993
-46% -$118K 0.01% 963
2022
Q1
$275K Sell
2,148
-314
-13% -$37.8K 0.01% 755
2021
Q4
$304K Sell
2,462
-366
-13% -$47.9K 0.01% 895
2021
Q3
$402K Sell
2,828
-403
-12% -$59.3K 0.01% 667
2021
Q2
$505K Sell
3,231
-190
-6% -$30.8K 0.01% 604
2021
Q1
$520K Buy
+3,421
New +$530K 0.01% 658

Other funds holding ZBH

Spire Wealth Management's ZBH Position: Q2 2026 in Review

Spire Wealth Management increased its Zimmer Biomet (ZBH) stake by 56% in Q2 2026, buying an estimated $789 and bringing the position to 25 shares worth $2.15K. The position accounts for ﹤0.01% of the portfolio, ranked #1996.

Spire Wealth Management first reported a position in ZBH in Q1 2021 and has held it in 22 quarters since. The position peaked at $1.94M in Q1 2025. 132 funds tracked by Wall St. Rank hold ZBH as of Q2 2026.

  • Spire Wealth Management held 25 shares of Zimmer Biomet worth $2.15K as of Q2 2026.
  • Spire Wealth Management bought 9 Zimmer Biomet shares in Q2 2026, an estimated $789.
  • Zimmer Biomet made up ﹤0.01% of Spire Wealth Management's portfolio in Q2 2026, its #1996 holding.
  • Spire Wealth Management first reported a position in Zimmer Biomet in Q1 2021 and has held it in 22 quarters since.
  • Spire Wealth Management's Zimmer Biomet position peaked at $1.94M in Q1 2025.
  • 132 funds tracked by Wall St. Rank held Zimmer Biomet as of Q2 2026.

Based on Spire Wealth Management's 13F filing for Q2 2026, filed 15 Jul 2026.